LOGIN  |  REGISTER
C4 Therapeutics

Recent Insider Transactions - Indaptus Therapeutics (NASDAQ: INDP)

Company
Name / Role
Date
Type
Price
# Shares
Value
Balance
NASDAQ INDP Indaptus Therapeutics
Newman Michael James / director, 10 percent owner, officer: CSO and Director
10/09/2024
Buy
$1.11
75,000
$83K
75,000
NASDAQ INDP Indaptus Therapeutics
Sassi Nir / officer: Chief Financial Officer
10/09/2024
Buy
$1.11
75,000
$83K
75,000
NASDAQ INDP Indaptus Therapeutics
Waltzman Roger J. / officer: Chief Medical Officer
10/09/2024
Buy
$1.11
75,000
$83K
75,000
NASDAQ INDP Indaptus Therapeutics
Linscott Walt Addison / officer: Chief Operating Officer
10/09/2024
Buy
$1.11
75,000
$83K
75,000
NASDAQ INDP Indaptus Therapeutics
Meckler Jeffrey A / director, officer: CEO and Director
10/09/2024
Buy
$1.11
75,000
$83K
75,000

COPYRIGHT ©2023 HEALTH STOCKS HUB